DOCSLIB.ORG

Student Opportunities

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

A Legacy of Caring Student Opportunities Throughout the Johnson & Johnson Family of Companies, we aim to make the world a better and healthier place through everything we do—the products we discover and develop, the positions we take on public policy issues, the way we run our business every day, and the programs and alliances we build and join. We see corporate citizenship, or sustainability, as intrinsic to all of Harnessing the sun’s power our activities, aligned with the spirit of caring that The Titusville campus of the emanates from Our Credo. Janssen Pharmaceutical Companies of Johnson & Johnson Sustainable business practices include quality and has the largest solar panel arrays safety, environmental protection and conservation in New Jersey. It is expected to Next Steps… of natural resources, improving access to health provide 70 percent of the site’s Would you like to be vital and make your care, ethical business practices, conducting annual electricity needs. mark within the Johnson & Johnson responsible research, and other areas. Through Family of Companies? our corporate giving, we work with partners on over 700 community-based programs that improve For more information and to apply for specific health and well-being in more than 50 countries. positions, please visit careers.jnj.com. In the last decade, Johnson & Johnson and its To use the “Search Jobs” function, first make operating companies have provided more than appropriate selections on the dropdown $4.3 billion in grants, product donations, and lists, then follow directions to view posted patient assistance. positions. Please apply only to positions in the country or countries where you are Green/Sustainability/Corporate Citizenship permanently authorized to work. Recognition Caring for mothers and • Ranked #5 on the Forbes list of America’s Top children NOTE: Many schools also require students to apply 10 Green Companies, 2011 When Yu Haixia’s son, Song through their Career Services Department by a • Johnson & Johnson was awarded the United Xiaoyan, was born, he could not specified deadline. Nations 2011 Humanitarian of the Year Award breathe on his own. He is one of thousands of children given new for our leading role in the Healthy Mother, life through China’s Neonatal Healthy Child initiative Resuscitation Program (NRP), a • Global FTSE4Good Index joint effort by Johnson & Johnson, CORCR12 Printed in USA. Printed on recycled paper. the Chinese Ministry of Health, Johnson & Johnson Services, Inc. is a member of the Johnson & Johnson Family of Companies. • Dow Jones Sustainability Index and the American Academy © Johnson & Johnson Services, Inc. 2012. Johnson & Johnson companies of Pediatrics. Learn More:http://www.jnj.com/responsibility are equal opportunity employers. Be Vital Dream… And never give up As students we all have dreams. But when it comes to entering your passion… the workplace, we wonder if we’ll have to settle for less. …it’s about being part of something Johnson & Johnson companies are looking for people with passion Johnson & Johnson companies invite you to go for more. and commitment to help us make the world a better, healthier place. We actively recruit high-potential MBA/graduate and undergraduate bigger than yourself yet at the same time Aspire… students for full-time positions, internships, and co-op opportunities. Our Credo, which has guided our business for almost 70 years, is all being valued for who you are Our family of over 250 companies can offer you the breadth and about the values we share and care about deeply—to do the right thing depth of opportunities to make your personal mark in a way that’s for our customers, our employees, our communities and environment, and meaningful to you. We provide both stability and flexibility, so you our stockholders. It’s also our commitment to you to provide a healthy and for all the things you can contribute can drive your career with confidence. Our three business segments, work environment, good balance between work and personal/family life, cross-functional teams, and global reach can open up a world of and challenging career opportunities. experience and opportunity. Follow your passion, and the mark you make will be both important and uniquely yours. …it also means becoming empowered Achieve… to drive your own career and to make your Wondering how you can move from where you are to where you want Check out real-life employee experiences to go? Not a problem. Our on-the-job training resources and leadership and career profiles at… development programs are world-class. The commitment of our leaders to , among colleagues http://careers.jnj.com/right-place-for-me unique personal mark coach and mentor is second to none. The people of Johnson & Johnson thrive in a collaborative, teamwork environment that can build up your who share the passion of caring— strengths and individuality. Your personal accomplishments will be recognized and rewarded as you move toward your goals. for each other, for customers and patients, and for communities around the world Be Vital Dream… And never give up As students we all have dreams. But when it comes to entering your passion… the workplace, we wonder if we’ll have to settle for less. …it’s about being part of something Johnson & Johnson companies are looking for people with passion Johnson & Johnson companies invite you to go for more. and commitment to help us make the world a better, healthier place. We actively recruit high-potential MBA/graduate and undergraduate bigger than yourself yet at the same time Aspire… students for full-time positions, internships, and co-op opportunities. Our Credo, which has guided our business for almost 70 years, is all being valued for who you are Our family of over 250 companies can offer you the breadth and about the values we share and care about deeply—to do the right thing depth of opportunities to make your personal mark in a way that’s for our customers, our employees, our communities and environment, and meaningful to you. We provide both stability and flexibility, so you our stockholders. It’s also our commitment to you to provide a healthy and for all the things you can contribute can drive your career with confidence. Our three business segments, work environment, good balance between work and personal/family life, cross-functional teams, and global reach can open up a world of and challenging career opportunities. experience and opportunity. Follow your passion, and the mark you make will be both important and uniquely yours. …it also means becoming empowered Achieve… to drive your own career and to make your Wondering how you can move from where you are to where you want Check out real-life employee experiences to go? Not a problem. Our on-the-job training resources and leadership and career profiles at… development programs are world-class. The commitment of our leaders to , among colleagues http://careers.jnj.com/right-place-for-me unique personal mark coach and mentor is second to none. The people of Johnson & Johnson thrive in a collaborative, teamwork environment that can build up your who share the passion of caring— strengths and individuality. Your personal accomplishments will be recognized and rewarded as you move toward your goals. for each other, for customers and patients, and for communities around the world Johnson & Johnson … the most comprehensive base of healthcare businesses in the world Consumer Segment Pharmaceuticals Segment Medical Devices & Diagnostics Segment Organization and university recruiting The Consumer segment includes a broad range of products The Pharmaceuticals segment’s broad portfolio focuses on unmet The Medical Devices & Diagnostics (MD&D) segment produces a broad The Johnson & Johnson Family of Companies is organized into used in the baby care, skin care, oral care, wound care, medical needs across several therapeutic areas. It includes products range of innovative products used primarily by healthcare professionals three business segments comprised of franchises and therapeutic and women’s healthcare fields, as well as nutritional and in the anti-infective, antipsychotic, cardiovascular, contraceptive, in the fields of orthopaedics, neurovascular, surgery, vision care, categories (see adjacent descriptions). Every year we recruit and hire over-the-counter pharmaceutical products and wellness dermatology, gastrointestinal, hematology, immunology, neurology, diabetes care, infection prevention, diagnostics, cardiovascular disease, high-potential undergraduate and graduate students for positions and prevention platforms. oncology, pain management, urology, and virology fields. sports medicine, and aesthetics. within our companies and leadership development programs. Business profile and performance Companies within the Consumer Business Segment Companies within the Pharmaceuticals Business Segment Companies within the MD&D Business Segment include: • More than 250 companies in 60 countries around the world include: Johnson & Johnson Consumer Companies, Inc. • include: Janssen R&D, LLC • Janssen A.I. • Janssen Diagnostics • Animas Corporation • Cordis Corporation • DePuy Synthes • Approximately 129,000 employees McNEIL-PPC, Inc. • McNeil Consumer Pharmaceuticals Co. • Janssen Global Services • Janssen Pharmaceuticals, Inc. • Janssen Companies of Johnson & Johnson • Ethicon, Inc. • Ethicon Endo- McNeil Healthcare LLC • McNeil Nutritionals, LLC • Neutrogena Services, LLC • Janssen Biotech, Inc. • Janssen Scientific Affairs • Surgery, Inc. • Johnson & Johnson
Recommended publications
  • Women in Business Awards Luncheon at the Hotel Irvine, Where Aston Martin Americas President Laura Schwab Delivered the Keynote Address

    Women in Business Awards Luncheon at the Hotel Irvine, Where Aston Martin Americas President Laura Schwab Delivered the Keynote Address

    10.5.20 SR_WIB.qxp_Layout 1 10/2/20 12:14 PM Page 29 WOMEN IN BUSINESS NOMINEES START ON PAGE B-60 INSIDE 2019 WINNERS GO BIG IN IRVINE, LAND NEW PARTNERS, INVESTMENTS PAGE 30 PRESENTED BY DIAMOND SPONSOR PLATINUM SPONSORS GOLD SPONSOR SILVER SPONSORS 10.5.20 SR_WIB.qxp_Layout 1 10/2/20 1:36 PM Page 30 30 ORANGE COUNTY BUSINESS JOURNAL www.ocbj.com OCTOBER 5, 2020 Winning Execs Don’t Rest on Their Laurels $1B Cancer Center Underway; Military Wins; Spanish Drug Investment Orange County’s business community last year celebrated the Business Journal’s 25th annual Women in Business Awards luncheon at the Hotel Irvine, where Aston Martin Americas President Laura Schwab delivered the keynote address. The winners, selected from 200 nominees, have not been resting on their laurels, even in the era of the coronavirus. Here are updates on what the five winners have been doing. —Peter J. Brennan Avatar Partners City of Hope Shortly after Marlo Brooke won the Busi- (AR) quality assurance solution for the U.S. As president of the City of Hope Orange employees down from Duarte. Area univer- ness Journal’s award for co-founding Hunt- Navy for aircraft wiring maintenance for the County, Annette Walker is orchestrating a sities could partner with City of Hope. ington Beach-based Avatar Partners Inc., Naval Air Systems Command’s Boeing V- $1 billion project to build one of the biggest, While the larger campus near the Orange she was accepted into the Forbes Technol- 22 Osprey aircraft. and scientifically advanced, cancer research County Great Park is being built, Walker in ogy Council, an invitation-only community Then the Air Force is using Avatar’s solu- centers in the world.
  • Complaint (PDF)

    Complaint (PDF)

    ATT: No (Attachments: No) Please print out and scan as first page for Complaints filed without attachments. MID-L-005993-18 10/08/2018 4:11:03 PM Pg 1 of 53 Trans ID: LCV20181750838 ROSS FELLER CASEY, LLP By: Robert Ross, Esquire (ID No. 28351986) Joel J. Feller, Esquire (ID No. 030791993) Brian J. McCormick, Jr., Esquire (ID No. 023981997) Dena R. Young, Esquire (ID No. 033022010) One Liberty Place 1650 Market Street, 34th Floor Philadelphia, PA 19103 Telephone: 215.574.2000 Fax: 215.574.3080 Attorneys for Plaintiffs KRISTEN WATSON and : JAMES WATSON IV, h/w : 1962 Winsome Lane : Adams, TN 37010, : SUPERIOR COURT OF NEW JERSEY : Plaintiffs : LAW DIVISION: MIDDLESEX COUNTY : v. : DOCKET NO. : Johnson & Johnson : One Johnson & Johnson Plaza : CIVIL ACTION New Brunswick, NJ 08933 : : Ethicon, Inc. : U.S. Route 22 : COMPLAINT Somerville, New Jersey, 08876 : : Mentor Worldwide LLC : 33 Technology Drive : Irvine, California, 92618, : : Defendants. : Plaintiffs Kristen and James Watson IV, h/w, by and through their attorneys, Ross Feller Casey, LLP, based on information and belief, and for causes of action against the Defendants Johnson & Johnson, Ethicon, Inc., and Mentor Worldwide, LLC, and each of them, hereby allege as follows: MID-L-005993-18 10/08/2018 4:11:03 PM Pg 2 of 53 Trans ID: LCV20181750838 INTRODUCTION 1. Plaintiffs KRISTEN AND JAMES WATSON IV, h/w, bring this action against Defendants Johnson & Johnson, Ethicon, Inc. and Mentor Worldwide LLC (“Mentor”) (hereinafter, collectively referred to as “Defendants”), and each of them, in relation to the design, manufacture, marketing, labeling and distribution of Mentor® Saline Breast Implants, the pervasive, reckless and continuous failure to comport with the Premarket Approval Application requirements imposed by the U.S.
  • Oct. 5-7, 2017

    Oct. 5-7, 2017

    2017 Navigating the Future: Individualizing Patient Care in the Face of Increasingly Complex Treatment Options OCT. 5-7, 2017 Bethesda North Marriott 5701 Marinelli Rd, Hotel & Conference Center Rockville, MD 20852 The Pulmonary Hypertension Association would like to thank Bayer HealthCare for sponsoring the 2017 PH Professional Network Symposium Program Book. Dear Friends Dear Friends, Welcome to the 2017 PH Professional Network Symposium, Navigating the Future: Individualizing Patient Care in the Face of Increasingly Complex Treatment Options. Since our last meeting in 2015, the field of pulmonary hypertension has continued to evolve with new medical and surgical treatment options and exciting research. With that in mind, our committee has worked diligently to provide an outstanding variety of topics and speakers that will build on our past knowledge as well as provide us with the newest advances in pulmonary Table of Contents hypertension. We have chosen sessions for both adult and pediatric health care professionals that we hope to be forward looking and inspirational. 1 Welcome to Symposium Symposium also provides a perfect backdrop for networking with your PH Welcome from the PHA colleagues. Evaluations from previous Symposia told us that this is one of 2 Board Chair the most valued aspects of our meeting. This year, we will host the second Symposium Networking Fun Walk, which supports PHA Conference patient Symposium History Highlights scholarships. The poster session will also be a great opportunity to engage in 3 thought-provoking discussion and ideas and this year, for the first time, CE Symposium Faculty and credits will be awarded for attending the poster session.
  • Johnson & Johnson Reports 2010 Second-Quarter Results

    Johnson & Johnson Reports 2010 Second-Quarter Results

    Johnson & Johnson Reports 2010 Second-Quarter Results: Sales of $15.3 Billion Increased 0.6% Versus 2009 Second-Quarter; EPS was $1.23 Excluding Special Items, 2010 Second-Quarter EPS was $1.21, an increase of 5.2%* NEW BRUNSWICK, N.J., July 20, 2010 /PRNewswire via COMTEX News Network/ -- Johnson & Johnson (NYSE: JNJ) today announced sales of $15.3 billion for the second quarter of 2010, an increase of 0.6% as compared to the second quarter of 2009. Operational results increased 0.1% and the positive impact of currency was 0.5%. Domestic sales declined 2.8%, while international sales increased 4.1%, reflecting operational growth of 3.0% and a positive currency impact of 1.1%. Net earnings and diluted earnings per share for the second quarter of 2010 were $3.4 billion and $1.23, respectively. Second- quarter 2010 net earnings included an after-tax gain of $67 million representing the net impact of litigation matters. Excluding this special item, net earnings for the current quarter were $3.4 billion and diluted earnings per share were $1.21, representing increases of 5.4% and 5.2%, respectively, as compared to the same period in 2009.* The Company updated its earnings guidance for full-year 2010 to $4.65 - $4.75 per share, which excludes the impact of special items. The Company's guidance now reflects the impact of the voluntary recalls announced earlier this year of certain over-the-counter medicines and the suspension of manufacturing at the McNeil Consumer Healthcare facility in Fort Washington, Pa., as well as unfavorable changes in foreign currency exchange rates.
  • Sales of $20.7 Billion Reflecting Growth of 1.9%, Operational Growth of 3.2

    Sales of $20.7 Billion Reflecting Growth of 1.9%, Operational Growth of 3.2

    RESULTS HAVE BEEN UPDATED IN ACCORDANCE WITH THE FORM 8-K FILED ON OCTOBER 23, 2019 JOHNSON & JOHNSON REPORTS 2019 THIRD-QUARTER RESULTS: • Sales of $20.7 billion reflecting growth of 1.9%, operational growth of 3.2%* and adjusted operational growth of 5.2%* • EPS of $0.66 decreased (54.2)%; adjusted EPS of $2.12 increased 3.4%* • Company increasing Full Year Sales and EPS guidance due to strong performance New Brunswick, N.J. (October 23, 2019) – Johnson & Johnson (NYSE: JNJ) today announced results for third-quarter 2019. “Our third-quarter results represent strong performance, driven by competitive underlying growth in Pharmaceuticals and Medical Devices, as well as continued optimization in our Consumer business,” said Alex Gorsky, Chairman and Chief Executive Officer. “As we look ahead, we remain confident in the strength of our broad-based business model, which is fueled by our disciplined portfolio management, focus on transformational innovation and dedicated employees around the world who position us for success today and well into the future.” OVERALL FINANCIAL RESULTS: THIRD QUARTER ($ in Millions, except EPS) 2019 2018 % Change Reported Sales $ 20,729 $ 20,348 1.9% Net Earnings 1,753 3,934 (55.4) EPS (diluted) $ 0.66 $ 1.44 (54.2) Non-GAAP* THIRD QUARTER ($ in Millions, except EPS) 2019 2018 % Change Operational Sales1,2 3.2% Adjusted Operational Sales1,3 5.2 Adjusted Net Earnings1,4 5,672 5,590 1.5 Adjusted EPS (diluted)1,4 $ 2.12 $ 2.05 3.4 1 Non-GAAP financial measure; refer to reconciliations of non-GAAP financial measures
  • Department of Public Health 105 Cmr 720.000

    Department of Public Health 105 Cmr 720.000

    105 CMR: DEPARTMENT OF PUBLIC HEALTH 105 CMR 720.000: LIST OF INTERCHANGEABLE DRUG PRODUCTS Section 720.001: Purpose 720.002: Citation 720.010: Scope and Application 720.020: Definitions Standards 720:040: Commission Review of Relevant Drug Products 720.050: List of Interchangeable Drug Products 720.060: Drug Products Excluded 720.070: Amendments to the Massachusetts List of Interchangeable Drugs Procedures for Amending List of Interchangeable Drug Products 720.080: Procedures for Amending the Massachusetts List of Interchangeable Drugs 720.081: Petition to Amend List of Interchangeable Drug Products 720.082: Commission Review of Petition 720.083: Notice of Public Comment Period 720.084: Commission Recommendation of Amendments to Department 720.090: Department Adoption of Amendments 720.100: Severability 720.200: Appendix A: List of Interchangeable Drugs 720.001: Purpose The purpose of 105 CMR 720.000 is to establish a drug formulary, or list of interchangeable drug products, for use by physicians, other practitioners, and pharmacists licensed to practice within the commonwealth, so that consumers of prescription drug products may realize cost savings by buying less expensive, safe drug products. 720.002: Citation 105 CMR 720.000 shall be known as the 105 CMR 720.000: Massachusetts List of Interchangeable Drug Products. 720.010: Scope and Application 105 CMR 720.000 establishes the list of interchangeable drug products from which a pharmacist must interchange a reasonably available less expensive drug product than that written, when a prescription written by a practitioner indicates "interchange". 105 CMR 720.000 also establishes criteria and procedures for inclusion of drug products on this list.
  • Exhibitor & Sponsor Program

    Exhibitor & Sponsor Program

    Exhibitor & Sponsor Program www.AtlanticDermConference.org @AtlanticDermADC The Philadelphia Dermatological Society and the Atlantic Derm Conference are pleased to acknowledge and express our sincere appreciation for our corporate sponsors, exhibitors, and commercial supporters. Disclosure of Commercial Support | This activity is supported by an educational donation provided by Amgen, an educational grant provided by Galderma Laboratories, LP, and an educational grant provided by Valeant Dermatology. SPONSORS DIAMOND PLATINUM GOLD SILVER Pharmaceuticals North America LLC www.AtlanticDermConference.org | Page 1 " !"!%! "%#%! !! !#! !% "!! #!!#%$ %"!"! ! !!!! " !%"!! '!!!&! ! "! ' !!! !!"!% "%# ! ( ! # ' % "& ## #!!#" #"$" Exhibitors Exhibitors 3Gen, Inc. | 31521 Rancho Viejo Road, #104, San Juan Capistrano, CA 92675 | 949.481.6384 | www.dermlite.com Table #15 ADDRESSING 3Gen manufactures the DermLite brand of skin imaging devices. THE TOUGHEST AbbVie | 1 N. Waukegan Road, North Chicago, IL 60064 | 847.937.7390 | abbvie.com | www.psoriasis.com Table #1 & 2 AbbVie is a global, research-based biopharmaceutical company which combines the focus of a leading-edge biotech with DERMATOLOGY the expertise and structure of a long-established pharmaceutical leader. AbbVie is committed to using unique approaches to innovation to develop and market advanced therapies that address some of the world’s most complex, serious diseases. CHALLENGES Actelion Pharmaceuticals US, Inc. | 5000 Shoreline Ct., South San Francisco,
  • Diabetes Close up December Supplement, 2005, No. 53 J&J To

    Diabetes Close up December Supplement, 2005, No. 53 J&J To

    Diabetes Close Up December supplement, 2005, No. 53 J&J To Buy Animas in Sublime Strategic Play T h e S h o r t e r V e r s i o n From the Editor: J&J’s LifeScan announced December 16 that it intends to buy Animas Corporation for $518 million in cash, or $24.50/share, a 35% premium over Animas’ closing price the 15th. We think this acquisition makes very good strategic sense – essentially, it’s the #1 glucose monitoring company buying the #2 pump player. In many respects, this was a classic J&J deal – Animas is newly profitable this year, the deal is immediately accretive, and it offers J&J an excellent leg up as it enters the pump market. Too, J&J had owned ~10% of Animas for some time. Now, while Animas is #2, it is still far behind leader Medtronic MiniMed, whose new(ish) leader, successful cardiac surgery veteran Bob Guezuraga has really impressed the diabetes community. Smart, ambitious, and seemingly hyper-focused, he appears very serious about taking the business to the next level and leaving success in diabetes as his legacy. What could be better for patients than significant focus industry-wide on better physiologic delivery? As competition heightens, we expect innovation to move faster – all good, from a patient perspective. Details on the acquisition are below – what J&J gets, what Animas gets, and what’s next. What a way to end what’s been a very dynamic year in diabetes … --Kelly L. Close DCU #53, December supplement 2005, J&J Buys Animas in Sublimely Strategic Deal.
  • Tips for Managing Treatment-Related Rash and Dry Skin

    Tips for Managing Treatment-Related Rash and Dry Skin

    RASH Tips for Managing Treatment-Related Rash and Dry Skin Presented by Stewart B. Fleishman, MD Continuum Cancer Centers of New York: Beth Israel & St. Luke’s-Roosevelt Lindy P. Fox, MD University of California San Francisco David H. Garfield, MD University of Colorado Comprehensive Cancer Center Carol S. Viele, RN, MS University of California San Francisco Carolyn Messner, DSW CancerCare Learn about: • Effects of targeted treatments on the skin • Managing rashes and dry skin • Treating nail conditions • Your support team Help and Hope CancerCare is a national nonprofit organization that provides free support services to anyone affected by cancer: people with cancer, caregivers, children, loved ones, and the bereaved. CancerCare programs—including counseling and support groups, education, financial assistance, and practical help—are provided by professional oncology social workers and are completely free of charge. Founded in 1944, CancerCare provided individual help to more than 100,000 people last year and had more than 1 million unique visitors to our websites. For more information, call 1-800-813-HOPE (4673) or visit www.cancercare.org. Contacting CancerCare National Office Administration CancerCare Tel: 212-712-8400 The material presented in this patient booklet is provided for your general 275 Seventh Avenue Fax: 212-712-8495 information only. It is not intended as medical advice and should not be relied New York, NY 10001 Email: [email protected] upon as a substitute for consultations with qualified health professionals who Email: [email protected] Website: www.cancercare.org are aware of your specific situation. We encourage you to take information and Services questions back to your individual health care provider as a way of creating a Tel: 212-712-8080 dialogue and partnership about your cancer and your treatment.
  • 2019 SMDP Biotech Training Agenda & Scholar Bios

    2019 SMDP Biotech Training Agenda & Scholar Bios

    2019 SMDP Biotech 1-5 June PHILADELPHIA www.icpdprograms.org 2019 Scientist Mentoring & Diversity Program for biotechnology (SMDP Biotech) www.icpdprograms.org Training Session June 1-6, 2019 in Philadelphia, PA about the program who attends: the one-year career mentoring program pairs ethnically diverse post-baccalaureate students, graduate students and post-doctoral researchers with industry mentors who work at biotechnology and consumer healthcare companies. With their mentors, SMDP Biotech Scholars attend a 5-day training session to learn about career opportunities in industry and receive career coaching. SMDP Scholars and Mentors also attend The BIO International Convention. how to dress, what to bring: business attire with comfortable shoes. Scholars, bring 100 business cards and 10 copies of your resume. Mentors will need business cards too. Informal dinner where to go: SMDP training Scholars and Mentors you’re Host Hotel session day 1 already on the guest list, we Mentors you will arrange the bus leaves the leave J&J Consumer at 5:15pm your own accommodation host hotel at 6:30am Ladder 15, 1528 Sansom Street, Scholars a shared room Scholars you will be Philadelphia, PA 19102 reservation has already been introduced to your made for you at this location: Mentors at the Reading Terminal MarKet Philadelphia 201, 201 N. 17th training session The bus leaves from the SMDP J&J Consumer, Street, Philadelphia, PA 19103 training session at 11:30am 199 Grandview Road, Corner of North 12th Street “Celebration of Mentoring Skillman, NJ 08558 and Arch Street (South Bldg. SK1912) & Diversity” reception ($10 will be provided) (Saturday, June 1st at 6pm) SMDP training The BIO Intl Convention Scholars and Mentors you’re session day 2 registration information will be already on the guest list the bus leaves the provided during the SMDP The Pyramid Club, host hotel at 7am training session.
  • Caring for the World . . .One Person at a Time™ Inspires and Unites the People of Johnson & Johnson

    Caring for the World . . .One Person at a Time™ Inspires and Unites the People of Johnson & Johnson

    OUR CARING TRANSFORMS 2007 Annual Report Caring for the world . .one person at a time™ inspires and unites the people of Johnson & Johnson. We embrace research and science—bringing innovative ideas, products and services to advance the health and well-being of people. Employees of the Johnson & Johnson Family of Companies work with partners in health care to touch the lives of over a billion people every day, throughout the world. The people in our more than 250 companies come to work each day inspired by their personal knowledge that their caring transforms people’s lives . one person at a time. On the following pages, we invite you to see for yourself. Our Caring Transforms ON THE COVER Johnson & Johnson is founding sponsor and continues to support Safe Kids Worldwide®. For 20 years the organization has grown, now teaching prevention as a way to save children’s lives in 17 countries around the world. In Brazil, Nayra Yara da Paz de Jesus carefully washes her hands, a safe, healthy habit she and other children are learning from a local Safe Kids® program. Find out more in our story on page 22. C H A I R M A N ’ S L E T T E R To Our Shareholders Caring for the health and well-being of people throughout the world is an extraordinary business. It is a business where people are passionate about their work, because it matters. It matters to their families, to their communities and to the world. It is a business filled with tremendous opportunity for leadership and growth in the 21st century; a business where unmet needs still abound and where people around the world WILLIAM C.
  • Open PDF File, 175.47 KB, for Top 100 Covered Recipients, Non Hospital

    Open PDF File, 175.47 KB, for Top 100 Covered Recipients, Non Hospital

    Top 100 Covered Recipients, Non Hospital, Detail Rank Recipient City State License License Covered Manufacturer Manufacturer Payment Number Total Fullname Type Number Recipient Name ID Categories of Payment ID Events QUADRANT HEALTH BEVERLY MA Clinical 22D2063293 357395 Novartis CC0243 Other 61 $2,251,831.00 STRATEGIES INC Laboratory Pharmaceuticals 1 Total for Covered Recipient : QUADRANT HEALTH STRATEGIES INC $2,251,831.00 BOSTON BOSTON MA Clinical 22D0996308 241308 Celgene CC0109 Grants/ 2 $30,000.00 UNIVERSITY Laboratory Corporation Educational SCHOOL OF Gifts MEDICINE Csl Behring Llc CC0101 Education/ 2 $5,000.00 Training Depuy CC0135 CMEs, third- 2 $26,000.00 Orthopaedics, Inc., party Conferences, or Meetings Other 1 $7,500.00 Dr. Reddy's CC0592 Grants/ 2 $121,820.00 Laboratories, Inc Educational Gifts Janssen Biotech, CC0194 Grants/ 2 $105,000.00 Inc. Educational Gifts Other 1 $1,500.00 Janssen CC0535 CMEs, third- 2 $175,000.00 Pharmaceuticals, party Inc. Conferences, or Meetings Novo Nordisk Inc. CC0006 Grants/ 2 $136,436.00 Educational Gifts Smith & Nephew, CC0402 CMEs, third- 1 $1,000.00 Inc. party Conferences, or Meetings Stryker Corporation CC0290 CMEs, third- 1 $1,000.00 party Conferences, or Meetings Takeda CC0300 CMEs, third- 2 $60,218.00 Pharmaceuticals party Aug 1, 2016 1 8:44:29 AM Top 100 Covered Recipients, Non Hospital, Detail Rank Recipient City State License License Covered Manufacturer Manufacturer Payment Number Total Fullname Type Number Recipient Name ID Categories of Payment ID Events BOSTON BOSTON MA Clinical 22D0996308 241308 America, Inc CC0300 Conferences, or UNIVERSITY Laboratory Meetings SCHOOL OF Grants/ 3 $800,000.00 MEDICINE Educational Gifts Valeant CC0346 CMEs, third- 2 $5,000.00 Pharmaceuticals party North America Conferences, or Meetings W.L.